Fluoroless slow-pathway cryoablation guided by electroanatomic mapping achieved 100% acute success in children and adolescents with AVNRT, with zero fluoroscopy used in 90% of procedures.
Cohort (n=21)
No
Does fluoroless slow-pathway cryoablation guided by electroanatomic mapping provide safe and effective treatment for AVNRT in children and adolescents?
Fluoroless slow-pathway cryoablation guided by electroanatomic mapping is a feasible, safe, and effective strategy for treating AVNRT in pediatric patients, minimizing radiation exposure.
BACKGROUND: Anatomical considerations and risks related to x-ray exposure make atrioventricular nodal reentrant tachycardia (AVNRT) ablation in pediatric patients a concerning procedure. We aimed to evaluate the feasibility, safety, and efficacy of performing fluoroless slow-pathway cryoablation guided by the electroanatomic (EA) mapping in children and adolescents. METHODS: Twenty-one consecutive patients (mean age 13.5 ± 2.4 years) symptomatic for AVNRT were prospectively enrolled to right atrium EA mapping and electrophysiological study prior to cryoablation. Cryoablation was guided by slow-pathway potential and performed using a 4-mm-tip catheter. RESULTS: Sustained slow-fast AVNRT was inducible in all the patients with a dual AV nodal physiology in 95%. Acute success was achieved in 100% of the patients with a median of two cryo-applications. Fluoroless ablation was feasible in 19 patients, while in two subjects 50 seconds and 45 seconds of x-ray were needed due to difficult progression of the catheters along the venous system. After a mean follow-up of 25 months, AVNRT recurred in five patients. All the recurrences were successfully treated with a second procedure. In three patients, a fluoroless cryoablation with a 6-mm-tip catheter was successfully performed, while in the remaining two patients, a single pulse of 60 seconds of radiofrequency energy was applied under fluoroscopic monitoring. No complications occurred. CONCLUSIONS: Combination of EA mapping systems and cryoablation may allow to perform fluoroless slow-pathway ablation for AVNRT in children and adolescents in the majority of patients. Fluoroless slow-pathway cryoablation showed a high efficacy and safety comparable to conventional fluoroscopy guided procedures.
Scaglione et al. (Tue,) conducted a cohort in Atrio-ventricular nodal reentrant tachycardia (AVNRT) (n=21). Fluoroless slow pathway cryoablation guided by electroanatomic mapping was evaluated on Acute success of AVNRT ablation. Fluoroless slow-pathway cryoablation guided by electroanatomic mapping achieved 100% acute success in children and adolescents with AVNRT, with zero fluoroscopy used in 90% of procedures.